How many studies have been conducted on Cefozopran?

BiohacksAI has indexed 182 PubMed studies on Cefozopran, including 7 randomized controlled trials (RCTs). 58% of studies involve human subjects.

What are the main research areas for Cefozopran?

The primary research domains for Cefozopran are 🫁 Respiratory, 🔬 Oncology, 😴 Sleep. This is based on analysis of 182 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Cefozopran

A fourth-generation cephalosporin antibacterial agent with a broad spectrum of activity against Gram-positive and Gram-negative bacteria. Cefozopran has a 1-methyltetrazolethiol (MTT) moiety at C-3 of its cephalosporin core.

182+ PubMed studies analyzed · 7 RCTs · Evidence Score: 49.4

Research Domains

Cefozopran has been studied across 9 research domains including 🫁 Respiratory, 🔬 Oncology, 😴 Sleep, 🧠 Focus & Attention, 🛡️ Immunity. The primary research focus is 🫁 Respiratory with 13% of studies addressing this area.

Loading evidence profile...

This evidence profile for Cefozopran is generated deterministically from 182 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.